Study Details

Study ID 1941-CL-0050
Study Title An exploratory study to investigate the effects of ipragliflozin (ASP1941) on glucose homeostasis and urinary glucose excretion in healthy subjects and subjects with type 2 diabetes mellitus (T2DM) Identifier NCT01611363
Compound Name ASP1941 / ipragliflozin
Medical Indication or Disease Type 2 diabetes mellitus
Study Sponsor Astellas Pharma Europe B.V.
Collaborator Not Applicable
Study Start Date 27-Oct-2011
Study Completion Date 03-Feb-2012
Clinical Study Result
Select the language
Plain Language Summary
Select the language